Pilot clinical study of quantitative ultrasound spectroscopy measurements of erythrocyte aggregation within superficial veins.


Journal

Clinical hemorheology and microcirculation
ISSN: 1875-8622
Titre abrégé: Clin Hemorheol Microcirc
Pays: Netherlands
ID NLM: 9709206

Informations de publication

Date de publication:
2020
Historique:
pubmed: 3 9 2019
medline: 3 7 2020
entrez: 3 9 2019
Statut: ppublish

Résumé

An enhanced inflammatory response is a trigger to the production of blood macromolecules involved in abnormally high levels of erythrocyte aggregation. This study aimed at demonstrating for the first time the clinical feasibility of a non-invasive ultrasound-based erythrocyte aggregation quantitative measurement method for potential application in critical care medicine. Erythrocyte aggregation was evaluated using modeling of the backscatter coefficient with the Structure Factor Size and Attenuation Estimator (SFSAE). SFSAE spectral parameters W (packing factor) and D (mean aggregate diameter) were measured within the antebrachial vein of the forearm and tibial vein of the leg in 50 healthy participants at natural flow and reduced flow controlled by a pressurized bracelet. Blood samples were also collected to measure erythrocyte aggregation ex vivo with an erythroaggregometer (parameter S10). W and Din vivo measurements were positively correlated with the ex vivoS10 index for both measurement sites and shear rates (correlations between 0.35-0.81, p < 0.05). Measurement at low shear rate was found to increase the sensitivity and reliability of this non-invasive measurement method. We behold that the SFSAE method presents systemic measures of the erythrocyte aggregation level, since results on upper and lower limbs were highly correlated.

Sections du résumé

BACKGROUND BACKGROUND
An enhanced inflammatory response is a trigger to the production of blood macromolecules involved in abnormally high levels of erythrocyte aggregation.
OBJECTIVE OBJECTIVE
This study aimed at demonstrating for the first time the clinical feasibility of a non-invasive ultrasound-based erythrocyte aggregation quantitative measurement method for potential application in critical care medicine.
METHODS METHODS
Erythrocyte aggregation was evaluated using modeling of the backscatter coefficient with the Structure Factor Size and Attenuation Estimator (SFSAE). SFSAE spectral parameters W (packing factor) and D (mean aggregate diameter) were measured within the antebrachial vein of the forearm and tibial vein of the leg in 50 healthy participants at natural flow and reduced flow controlled by a pressurized bracelet. Blood samples were also collected to measure erythrocyte aggregation ex vivo with an erythroaggregometer (parameter S10).
RESULTS RESULTS
W and Din vivo measurements were positively correlated with the ex vivoS10 index for both measurement sites and shear rates (correlations between 0.35-0.81, p < 0.05). Measurement at low shear rate was found to increase the sensitivity and reliability of this non-invasive measurement method.
CONCLUSIONS CONCLUSIONS
We behold that the SFSAE method presents systemic measures of the erythrocyte aggregation level, since results on upper and lower limbs were highly correlated.

Identifiants

pubmed: 31476146
pii: CH180541
doi: 10.3233/CH-180541
pmc: PMC7242846
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

109-126

Références

Biorheology. 1988;25(1-2):367-75
pubmed: 3196834
Clin Hemorheol Microcirc. 2009;42(2):75-97
pubmed: 19433882
J Chiropr Med. 2016 Jun;15(2):155-63
pubmed: 27330520
Clin Hemorheol Microcirc. 2006;35(1-2):307-10
pubmed: 16899949
Biorheology. 1996 Jul-Oct;33(4-5):365-77
pubmed: 8977661
IEEE Trans Biomed Eng. 1997 Jul;44(7):549-54
pubmed: 9210814
Am J Physiol. 1996 Dec;271(6 Pt 2):H2346-52
pubmed: 8997292
Science. 1982 Dec 24;218(4579):1321-3
pubmed: 7146914
PLoS One. 2015 Apr 23;10(4):e0124712
pubmed: 25906140
J Acoust Soc Am. 2007 Jul;122(1):645-56
pubmed: 17614521
Int J Low Extrem Wounds. 2003 Mar;2(1):13-8
pubmed: 15866822
Ultrasound Med Biol. 2018 Jul;44(7):1303-1317
pubmed: 29661483
Clin Hemorheol Microcirc. 2013;55(1):63-73
pubmed: 23455838
Ann Biomed Eng. 2000 Apr;28(4):399-407
pubmed: 10870896
Diabetes Care. 2008 Jul;31(7):1400-2
pubmed: 18375419
Obes Res. 2003 Mar;11(3):403-7
pubmed: 12634437
J Acoust Soc Am. 2008 Apr;123(4):EL85-91
pubmed: 18396926
Ultrasound Med Biol. 2017 Dec;43(12):2871-2881
pubmed: 28893425
Clin Hemorheol Microcirc. 2000;22(2):91-7
pubmed: 10831060
Ultrason Imaging. 2006 Apr;28(2):83-96
pubmed: 17094689
Ultrasound Med Biol. 1997;23(6):933-8
pubmed: 9300997
Biorheology. 1997 Nov-Dec;34(6):443-70
pubmed: 9640358
J Thromb Haemost. 2011 Mar;9(3):481-8
pubmed: 21143377
J Clin Invest. 1968 Jun;47(6):1447-54
pubmed: 16695950
Obesity (Silver Spring). 2007 Aug;15(8):2128-34
pubmed: 17712132
Biorheology. 1983;20(5):569-77
pubmed: 6203572
J Acoust Soc Am. 2010 Feb;127(2):1104-15
pubmed: 20136231
Exp Fluids. 2011 May 1;50(5):1247-1259
pubmed: 24795497
J Acoust Soc Am. 2011 Apr;129(4):2269-77
pubmed: 21476682
J Acoust Soc Am. 1988 Jul;84(1):52-8
pubmed: 3411055
Clin Hemorheol Microcirc. 2001;25(2):43-8
pubmed: 11790869
Biorheology. 1987;24(5):451-61
pubmed: 3446295
Pediatr Infect Dis J. 2004 Feb;23(2):159-60
pubmed: 14872184

Auteurs

Boris Chayer (B)

Laboratory of Biorheology and Medical Ultrasonics, University of Montreal Hospital Research Center (CRCHUM), Montréal, QC, Canada.

Louise Allard (L)

Laboratory of Biorheology and Medical Ultrasonics, University of Montreal Hospital Research Center (CRCHUM), Montréal, QC, Canada.

Zhao Qin (Z)

Laboratory of Biorheology and Medical Ultrasonics, University of Montreal Hospital Research Center (CRCHUM), Montréal, QC, Canada.

Julian Garcia-Duitama (J)

Laboratory of Biorheology and Medical Ultrasonics, University of Montreal Hospital Research Center (CRCHUM), Montréal, QC, Canada.
Institute of Biomedical Engineering, University of Montreal, Montréal, QC, Canada.

Laurence Roger (L)

Laboratory of Biorheology and Medical Ultrasonics, University of Montreal Hospital Research Center (CRCHUM), Montréal, QC, Canada.

François Destrempes (F)

Laboratory of Biorheology and Medical Ultrasonics, University of Montreal Hospital Research Center (CRCHUM), Montréal, QC, Canada.

Jean-François Cailhier (JF)

CRCHUM and Department of Medicine, University of Montreal, Montréal, QC, Canada.

André Denault (A)

Montreal Heart Institute, University of Montreal Hospital, and Department of Anesthesiology, University of Montreal, Montréal, QC, Canada.

Guy Cloutier (G)

Laboratory of Biorheology and Medical Ultrasonics, University of Montreal Hospital Research Center (CRCHUM), Montréal, QC, Canada.
Institute of Biomedical Engineering, University of Montreal, Montréal, QC, Canada.
Department of Radiology, Radio-Oncology and Nuclear Medicine, University of Montreal, Montreal, QC, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH